{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:47:34Z","timestamp":1767142054581,"version":"build-2238731810"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11096-021-01356-6","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T19:03:47Z","timestamp":1641841427000},"page":"399-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-effectiveness of check of medication appropriateness: methodological approach"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-7711","authenticated-orcid":false,"given":"Erinn","family":"D\u2019hulster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Quintens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raf","family":"Bisschops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Willems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willy E.","family":"Peetermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Y.","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/IPRP.S108047","volume":"6","author":"K Dalton","year":"2017","unstructured":"Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37\u201346. https:\/\/doi.org\/10.2147\/IPRP.S108047.","journal-title":"Integr Pharm Res Pract"},{"issue":"13","key":"1356_CR2","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.2165\/00003495-200565130-00001","volume":"65","author":"HJ Guchelaar","year":"2005","unstructured":"Guchelaar HJ, Colen HBB, Kalmeijer MD, et al. Medication errors: hospital pharmacist perspective. Drugs. 2005;65(13):1735\u201346. https:\/\/doi.org\/10.2165\/00003495-200565130-00001.","journal-title":"Drugs"},{"issue":"5","key":"1356_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2165\/00002018-200730050-00003","volume":"30","author":"A Kr\u00e4henb\u00fchl-Melcher","year":"2007","unstructured":"Kr\u00e4henb\u00fchl-Melcher A, Schlienger R, Lampert M, et al. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379\u2013407. https:\/\/doi.org\/10.2165\/00002018-200730050-00003.","journal-title":"Drug Saf"},{"issue":"6","key":"1356_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jval.2012.05.007","volume":"15","author":"D Rottenkolber","year":"2012","unstructured":"Rottenkolber D, Hasford J, Stausberg J. Costs of adverse drug events in German hospitals-a microcosting study. Value Health. 2012;15(6):868\u201375. https:\/\/doi.org\/10.1016\/j.jval.2012.05.007.","journal-title":"Value Health"},{"issue":"10","key":"1356_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2165\/11536800-000000000-00000","volume":"33","author":"LHF Hoonhout","year":"2010","unstructured":"Hoonhout LHF, de Bruijne MC, Wagner C, et al. Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands. Drug Saf. 2010;33(10):853\u201364. https:\/\/doi.org\/10.2165\/11536800-000000000-00000.","journal-title":"Drug Saf"},{"issue":"3","key":"1356_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/s1553-7250(12)38016-1","volume":"38","author":"BL Hug","year":"2012","unstructured":"Hug BL, Keohane C, Seger DL, et al. The costs of adverse drug events in community hospitals. Jt Comm J Qual Patient Saf. 2012;38(3):120\u20136. https:\/\/doi.org\/10.1016\/s1553-7250(12)38016-1.","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"4","key":"1356_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40266-016-0348-3","volume":"33","author":"J Gallagher","year":"2016","unstructured":"Gallagher J, O\u2019Sullivan D, McCarthy S, et al. Structured pharmacist review of medication in older hospitalised patients: a cost-effectiveness analysis. Drugs Aging. 2016;33(4):285\u201394. https:\/\/doi.org\/10.1007\/s40266-016-0348-3.","journal-title":"Drugs Aging"},{"issue":"9","key":"1356_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/archinte.166.9.955","volume":"166","author":"PJ Kaboli","year":"2006","unstructured":"Kaboli PJ, Hoth AB, McClimon BJ, et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955\u201364. https:\/\/doi.org\/10.1001\/archinte.166.9.955.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1356_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12911-019-0748-5","volume":"19","author":"C Quintens","year":"2019","unstructured":"Quintens C, De Rijdt T, Van Nieuwenhuyse T, et al. Development and implementation of \u201ccheck of medication appropriateness\u201d (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance. BMC Med Inform Decis Mak. 2019;19(1):29. https:\/\/doi.org\/10.1186\/s12911-019-0748-5.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"1356_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ejp.1705","volume":"25","author":"C Quintens","year":"2021","unstructured":"Quintens C, De Coster J, Van der Linden L, et al. Impact of check of medication appropriateness (CMA) in optimizing analgesic prescribing: an interrupted time series analysis. Eur J Pain. 2021;25(3):704\u201313. https:\/\/doi.org\/10.1002\/ejp.1705.","journal-title":"Eur J Pain"},{"key":"1356_CR11","doi-asserted-by":"publisher","unstructured":"Quintens C, Peetermans WE, Lagrou K, et al. The effectiveness of Check of Medication Appropriateness for antimicrobial stewardship: an interrupted time series analysis. J Antimicrob Chemother. 2021;dkab364. https:\/\/doi.org\/10.1093\/jac\/dkab364.","DOI":"10.1093\/jac\/dkab364"},{"key":"1356_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11096-014-0008-9","volume":"36","author":"J Gallagher","year":"2014","unstructured":"Gallagher J, McCarthy S, Byrne S. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 2014;36:1101\u201314. https:\/\/doi.org\/10.1007\/s11096-014-0008-9.","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"1356_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijmedinf.2014.05.003","volume":"83","author":"KM Vermeulen","year":"2014","unstructured":"Vermeulen KM, van Doormaal JE, Zaal RJ, et al. Cost-effectiveness of an electronic medication ordering system (CPOE\/CDSS) in hospitalized patients. Int J Med Inform. 2014;83(8):572\u201380. https:\/\/doi.org\/10.1016\/j.ijmedinf.2014.05.003.","journal-title":"Int J Med Inform"},{"issue":"12","key":"1356_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s002280000260","volume":"56","author":"R Bordet","year":"2001","unstructured":"Bordet R, Gautier S, Le Louet H, et al. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol. 2001;56(12):935\u201341. https:\/\/doi.org\/10.1007\/s002280000260.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"1356_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/pds.2118","volume":"20","author":"D Rottenkolber","year":"2011","unstructured":"Rottenkolber D, Schmiedl S, Rottenkolber M, et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf. 2011;20(6):626\u201334. https:\/\/doi.org\/10.1002\/pds.2118.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1356_CR16","doi-asserted-by":"publisher","unstructured":"Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the american heart association. Circulation. 2020;13;142(15):e214-e233. https:\/\/doi.org\/10.1161\/CIR.0000000000000905.","DOI":"10.1161\/CIR.0000000000000905"},{"issue":"25","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.jacc.2008.09.018","volume":"52","author":"DJ Cohen","year":"2008","unstructured":"Cohen DJ, Reynolds MR. Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol. 2008;52(25):2119\u201326. https:\/\/doi.org\/10.1016\/j.jacc.2008.09.018.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1356_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1536\/ihj.17-365","volume":"58","author":"S Kodera","year":"2017","unstructured":"Kodera S, Kiyosue A, Ando J, et al. Cost- effectiveness analysis of cardiovascular disease treatment in Japan. Int Heart J. 2017;58(6):847\u201352. https:\/\/doi.org\/10.1536\/ihj.17-365.","journal-title":"Int Heart J"},{"issue":"2","key":"1356_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.otsr.2016.01.002","volume":"102","author":"B Dervaux","year":"2016","unstructured":"Dervaux B. Stakes and methods in economic evaluation. Orthop Traumatol Surg Res. 2016;102(2):141\u20132. https:\/\/doi.org\/10.1016\/j.otsr.2016.01.002.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"7","key":"1356_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/pds.3792","volume":"24","author":"MJ Warnier","year":"2015","unstructured":"Warnier MJ, Rutten FH, Souverein PC, et al. Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiol Drug Saf. 2015;24(7):701\u20138. https:\/\/doi.org\/10.1002\/pds.3792.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1356_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ijcard.2017.05.072","volume":"243","author":"E Vandael","year":"2017","unstructured":"Vandael E, Vandenberk B, Vandenberghe J, et al. Incidence of Torsade de Pointes in a tertiary hospital population. Int J Cardiol. 2017;243:511\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2017.05.072.","journal-title":"Int J Cardiol"},{"issue":"8","key":"1356_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40266-018-0564-0","volume":"35","author":"GL O\u2019Brien","year":"2018","unstructured":"O\u2019Brien GL, O\u2019Mahony D, Gillespie P, et al. Cost-effectiveness analysis of a physician-implemented medication screening tool in older hospitalised patients in ireland. Drugs Aging. 2018;35(8):751\u201362. https:\/\/doi.org\/10.1007\/s40266-018-0564-0.","journal-title":"Drugs Aging"},{"issue":"9","key":"1356_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.cgh.2007.04.019","volume":"5","author":"G Singh","year":"2007","unstructured":"Singh G, Lingala V, Wang H, et al. Use of health care resources and cost of care for adults with constipation. Clin Gastroenterol Hepatol. 2007;5(9):1053\u20138. https:\/\/doi.org\/10.1016\/j.cgh.2007.04.019.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1356_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007230","volume":"5","author":"HE Campbell","year":"2015","unstructured":"Campbell HE, Stokes EA, Bargo D, et al. Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial. BMJ Open. 2015;5(4): e007230. https:\/\/doi.org\/10.1136\/bmjopen-2014-007230.","journal-title":"BMJ Open"},{"issue":"12","key":"1356_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4253\/wjge.v11.i12.561","volume":"11","author":"FG Haddad","year":"2019","unstructured":"Haddad FG, El Imad T, Nassani N, et al. In-hospital acute upper gastrointestinal bleeding: what is the scope of the problem? World J Gastrointest Endosc. 2019;11(12):561\u201372. https:\/\/doi.org\/10.4253\/wjge.v11.i12.561.","journal-title":"World J Gastrointest Endosc"},{"issue":"5","key":"1356_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.gie.2013.10.009","volume":"79","author":"R Marmo","year":"2014","unstructured":"Marmo R, Koch M, Cipoletta L, et al. Predicting mortality in patients with in-hospital nonvariceal upper GI bleeding: a prospective, multicenter database study. Gastrointest Endosc. 2014;79(5):741-9.e1. https:\/\/doi.org\/10.1016\/j.gie.2013.10.009.","journal-title":"Gastrointest Endosc"},{"issue":"14","key":"1356_CR27","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1161\/01.CIR.0000143150.13727.19","volume":"110","author":"AP van Alem","year":"2004","unstructured":"van Alem AP, Dijkgraaf MGW, Tijssen JGP, et al. Health system costs of out-of-hospital cardiac arrest in relation to time to shock. Circulation. 2004;110(14):1967\u201373. https:\/\/doi.org\/10.1161\/01.CIR.0000143150.13727.19.","journal-title":"Circulation"},{"issue":"11","key":"1356_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/SMJ.0b013e318157ec8f","volume":"100","author":"JA DiPalma","year":"2007","unstructured":"DiPalma JA, Cleveland MB, McGowan J, et al. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J. 2007;100(11):1085\u201390. https:\/\/doi.org\/10.1097\/SMJ.0b013e318157ec8f.","journal-title":"South Med J"},{"issue":"2","key":"1356_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/gut.2010.227132","volume":"60","author":"AC Ford","year":"2011","unstructured":"Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209\u201318. https:\/\/doi.org\/10.1136\/gut.2010.227132.","journal-title":"Gut"},{"issue":"5","key":"1356_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/s0025-7125(05)70282-0","volume":"84","author":"MA Fallah","year":"2000","unstructured":"Fallah MA, Prakash C, Edmundowicz S. Acute gastrointestinal bleeding. Med Clin North Am. 2000;84(5):1183\u2013208. https:\/\/doi.org\/10.1016\/s0025-7125(05)70282-0.","journal-title":"Med Clin North Am"},{"issue":"12","key":"1356_CR31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/apt.13642","volume":"43","author":"JQ Yuan","year":"2016","unstructured":"Yuan JQ, Tsoi KKF, Yang M, et al. Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity. Aliment Pharmacol Ther. 2016;43(12):1262\u201375. https:\/\/doi.org\/10.1111\/apt.13642.","journal-title":"Aliment Pharmacol Ther"},{"key":"1356_CR32","unstructured":"Cohagan B, Brandis D. Torsade de Pointes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459388\/. Accessed December 2020."},{"issue":"2","key":"1356_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2036.2009.04191.x","volume":"31","author":"RR Taylor","year":"2010","unstructured":"Taylor RR, Guest JF. The cost-effectiveness of macrogol 3350 compared to lactulose in the treatment of adults suffering from chronic constipation in the UK. Aliment Pharmacol Ther. 2010;31(2):302\u201312. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04191.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1356_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S2468-1253(18)30008-6","volume":"3","author":"AD Farmer","year":"2018","unstructured":"Farmer AD, Bruckner Holt C, Downes TJ, et al. Pathophysiology, diagnosis, and management of opioid-induced constipation. Lancet Gastroenterol Hepatol. 2018;3(3):203\u201312. https:\/\/doi.org\/10.1016\/S2468-1253(18)30008-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1356_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","volume":"156","author":"SD Crockett","year":"2019","unstructured":"Crockett SD, Greer KB, Heidelbaugh JJ, et al. American gastroenterological association institute guideline on the medical management of opioid-induced constipation. Gastroenterology. 2019;156(1):218\u201326. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.016.","journal-title":"Gastroenterology"},{"issue":"12","key":"1356_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11864-019-0686-6","volume":"20","author":"R Mes\u00eda","year":"2019","unstructured":"Mes\u00eda R, Virizuela Echaburu JA, G\u00f3mez J, et al. Opioid-induced constipation in oncological patients: new strategies of management. Curr Treat Options Oncol. 2019;20(12):91. https:\/\/doi.org\/10.1007\/s11864-019-0686-6.","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"1356_CR37","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/art.27412","volume":"62","author":"EL Masso Gonzalez","year":"2010","unstructured":"Masso Gonzalez EL, Patrignani P, Tacconelli S, et al. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010;62(6):1592\u2013601. https:\/\/doi.org\/10.1002\/art.27412.","journal-title":"Arthritis Rheum"},{"key":"1356_CR38","unstructured":"Woosley RL, Romero KA. QTdrugs List, December 2015, AZCERT, Inc. 1822 Innovation Park Dr., Oro Valley, AZ 85755. http:\/\/www.crediblemeds.org. Accessed December 2020."},{"issue":"12","key":"1356_CR39","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1111\/bcp.13740","volume":"84","author":"E Vandael","year":"2018","unstructured":"Vandael E, Vandenberk B, Vanderberghe J, et al. A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model. Br J Clin Pharmacol. 2018;84(12):2824\u201335. https:\/\/doi.org\/10.1111\/bcp.13740.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1356_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003264","volume":"5","author":"B Vandenberk","year":"2016","unstructured":"Vandenberk B, Vandael E, Robyns R, et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;5(6): e003264. https:\/\/doi.org\/10.1161\/JAHA.116.003264.","journal-title":"J Am Heart Assoc"}],"updated-by":[{"DOI":"10.1007\/s11096-022-01392-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T00:00:00Z","timestamp":1647734400000}}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-021-01356-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T04:08:26Z","timestamp":1649909306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-021-01356-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s11096-021-01356-6","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"12 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11096-022-01392-w","URL":"https:\/\/doi.org\/10.1007\/s11096-022-01392-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RW reports research funding from Abbott, Biotronik, Boston Scientific, Medtronic; speakers and consultancy fees from Daichi Sankyo, Bayer, Boehringer Ingelheim, Medtronic, Boston Scientific, Biotronik, Abbott, Microport. RB reports research funding from Fujifilm, Pentax and Medtronic; speakers and consultancy fees from Fujifilm, Pentax, Medtronic, Norgine, CDx diagnostics, Ipsen. None of these are relevant for the content of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}